Budapest, Hungary

Kálmán Takács

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: N-Gene Research Laboratories, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kálmán Takács. Retrieved from https://idiyas.com/inventor/kálmán-takács

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kálmán Takács: Innovator in Obesity Treatment

Introduction

Kálmán Takács is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of obesity treatment through his innovative research and development. His work focuses on the prevention and treatment of weight gain, showcasing his commitment to addressing a pressing health issue.

Latest Patents

Kálmán Takács holds a patent for a compound known as O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime (BGP-15). This compound, or a pharmaceutically suitable acid addition salt thereof, can be utilized for the prevention or reduction of weight gain, as well as for decreasing the rate of body weight gain. This patent highlights his dedication to finding effective solutions for obesity.

Career Highlights

He is associated with N-gene Research Laboratories, Inc., where he continues to advance his research in the field of pharmaceuticals. His work has the potential to impact many lives by providing new avenues for obesity treatment.

Collaborations

Kálmán has collaborated with esteemed colleagues such as Péter Literáti Nagy and Zoltán Szilvássy. These partnerships have likely enriched his research and contributed to the development of innovative solutions in his field.

Conclusion

Kálmán Takács is a pioneering inventor whose work in obesity treatment is both innovative and impactful. His contributions through patents and collaborations reflect his commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…